Skip to main content

CRYO CELL INTERNATIONAL INC

For the period ended Aug 31, 2025. Filed Oct 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Aug 31, 2025 · Filed Oct 15, 2025

CCEL$4.87-0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Stockholders’ Deficit

Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at May 31, 202514,869,619$148,696$44,605,887$(24,944,175)$(35,370,213)$(15,559,805)
Exercise of stock options7,5007523,02623,101
Compensatory element of stock options36,780$36,780
Treasury stock(80,883)(80,883)
Net income749,408$749,408
Balance at August 31, 202514,877,119$148,771$44,665,693$(25,025,058)$(34,620,805)$(14,831,399)
Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at November 30, 202414,869,619$148,696$44,268,469$(24,855,556)$(32,777,626)$(13,216,017)
Exercise of stock options7,5007523,02623,101
Compensatory element of stock options374,198374,198
Treasury stock(169,502)(169,502)
Dividends declared ($0.40 per share)(3,231,227)(3,231,227)
Net income1,388,0481,388,048
Balance at August 31, 202514,877,119$148,771$44,665,693$(25,025,058)$(34,620,805)$(14,831,399)
Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at May 31, 202414,849,246$148,492$43,896,637$(24,839,156)$(29,947,151)$(10,741,178)
Exercise of stock options37349981,002
Compensatory element of stock options145,941145,941
Treasury stock(16,400)(16,400)
Net income1,051,6791,051,679
Balance at August 31, 202414,849,619$148,496$44,043,576$(24,855,556)$(28,895,472)$(9,558,956)
Additional · Total
Common Stock · Paid-In · Treasury · Accumulated · Stockholders'
Shares · Amount · Capital · Stock · Deficit · Deficit
Balance at November 30, 202314,849,246$148,492$43,411,143$(23,431,685)$(31,159,182)$(11,031,232)
Exercise of stock options37349981,002
Compensatory element of stock options631,435631,435
Treasury stock(1,423,871)(1,423,871)
Net income2,263,7102,263,710
Balance at August 31, 202414,849,619$148,496$44,043,576$(24,855,556)$(28,895,472)$(9,558,956)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.